Insider Transactions in Q3 2020 at Pmv Pharmaceuticals, Inc. (PMVP)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2020
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
950,000
+35.71%
|
$17,100,000
$18.0 P/Share
|
|
Sep 29
2020
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
760,265
+50.0%
|
-
|
|
Sep 29
2020
|
Euclidean Capital LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
4,179,416
+50.0%
|
-
|
|
Sep 29
2020
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
6,114,330
+25.36%
|
-
|
|
Sep 29
2020
|
Boxer Capital, LLC |
BUY
Conversion of derivative security
|
Indirect |
60,837
+40.81%
|
-
|
|
Sep 29
2020
|
Boxer Capital, LLC |
BUY
Conversion of derivative security
|
Direct |
1,318,236
+26.01%
|
-
|
|
Sep 25
2020
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
950,000
+50.0%
|
$17,100,000
$18.0 P/Share
|
|
Sep 25
2020
|
Boxer Capital, LLC |
BUY
Open market or private purchase
|
Direct |
950,000
+50.0%
|
$17,100,000
$18.0 P/Share
|